Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Bluegreen who wrote (5880)	11/6/1998 4:18:00 PM
From: Rocketman	Respond to of 9719

Now George, there is no need to protect us from Bluegreen, we like to hear what others think. I actually thought XOMA was a good short term buy when it was down in the $2's, not as sure in the $4's. As all biotech boats have risen, we have gotten back some buying power, but when XOMA was in the $2's cash was much more limited. My only regret with AMLN was not buying 10,000 shares instead of 2,000 but my partner was holding his nose so tightly that 2000 was the most he would agree to, and then only for "a few days". The real gold was struck today with a short on GERN. Made $3800 so far today. Should have shorted more when it popped back up in the $20s, but didn't want to stretch our necks that far, especially since this has been done entirely without V1's involvement. This sucker is going to drop for a couple of weeks I figure. Hang in there and I hope XOMA makes you rich! The world needs BPI to work. Rman